Andere Sprachen Innoviva, Inc.

Aktien

A2AC9U

US45781M1018

INVA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 31.05.2024			% 5 Tage	% 1. Jan.
15,79 ^USD	+2,87 %		+0,06 %	-1,56 %

20.05.	Zai Lab und Innoviva-Tochtergesellschaft erhalten in China Zulassung für Behandlung von Krankenhausinfektionen	MT
15.05.	Transcript : Innoviva, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Zai Lab, Innoviva Subsidiary Receive China Approval for Hospital Infection Treatment	20.05.
Transcript : Innoviva, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 09:20 AM	15.05.
Innoviva, Inc. Appoints Derek Small to the Board of Directors	08.05.
Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc.?s Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024	24.04.
Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit	04.03.
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29.02.
Innoviva, Inc. Appoints David Altarac as Chief Medical Officer of Innoviva Specialty Therapeutics	06.02.
Innoviva Insider Sold Shares Worth $153,810, According to a Recent SEC Filing	17.11.
Innoviva, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	01.11.
Innoviva Names Stephen Basso as Finance Chief	28.08.23
Innoviva, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02.08.23
Innoviva, Inc. Announces Resignation of Deborah L. Birx as Member of the Board of Directors and Chair of the Audit Committee	11.07.23
Transcript : Innoviva, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 02:00 PM	12.06.23
Insider Buy: Innoviva	31.05.23
Innoviva Unit Says FDA Approves Xacduro for Treatment of Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia	24.05.23
Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	09.05.23
Innoviva, Inc. Announces Retirement of George Bickerstaff, III, as Board Chairman	28.04.23
MÄRKTE USA/Wall Street dürfte Schwung des späten Vortageshandels halten	18.04.23
Innoviva Says FDA's Antimicrobial Drugs Advisory Committee to Convene in April to Review New Drug Application for Sulbactam-Durlobactam	14.03.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Innoviva, Inc.

Aktien

A2AC9U

US45781M1018

INVA

Andere Sprachen

Filter